SkinCeuticals, CeraVe, La Roche-Posay & Melanoma Research Alliance Launch Three-Year Partnership in the United States
An annual Team Science Award will be Issued to Researchers Studying Artificial Intelligence (AI)...
Read More
Tag: Melanoma
Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma
Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for...
Read MorePromising new drug stops spread of melanoma by 90 percent
Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells...
Read MoreASDS: Costs to treat non-melanoma skin cancers in line with costs for other cancers
While skin cancer remains a growing major public health problem, a recent study focusing instead on the disease’s economic impact (more…)
Read MorePain and itch may be signs of skin cancer
Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely (more…)
Read MoreMelanoma recurs after 10 years in 6% of patients
Recurrence of melanoma 10 or more years after initial treatment is more common than previously thought, occurring in more than...
Read MoreEditorial: SPOT Skin Cancer
Coco Chanel is often accredited with making the sun tan popular in the 1920s. Prior to that, having tanned skinned signified (more…)
Read More
November/December Issue
